Treatment with GLP-1 was associated with a significantly lower risk of epilepsy (16%) compared to DPP-4 treatment
Enhanced Satiety: The protein and fat content can significantly increase feelings of fullness, which can be beneficial when Mounjaro is already reducing appetite
Myth 1: GLP-1 Medications Are Only for Diabetics Reality Check: While its true that semaglutide and tirzepatide were initially developed for diabetes management, their benefits extend far beyond controlling blood sugar
State Health Plan spending on GLP-1 drugs such as Wegovy rose from about $3 million per month in around 2021-2022 to more than $14 million per month in 2023, making In 2023, the drugs accounted for roughly 10% of the $1 billion the plan spends on all prescription drugs
Choose Bland Foods : When nausea is strong, stick to bland, easy-to-digest foods like toast, rice, bananas, and broth